158 related articles for article (PubMed ID: 11375959)
1. Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-beta.
Okuno M; Akita K; Moriwaki H; Kawada N; Ikeda K; Kaneda K; Suzuki Y; Kojima S
Gastroenterology; 2001 Jun; 120(7):1784-800. PubMed ID: 11375959
[TBL] [Abstract][Full Text] [Related]
2. Camostat mesilate inhibits prostasin activity and reduces blood pressure and renal injury in salt-sensitive hypertension.
Maekawa A; Kakizoe Y; Miyoshi T; Wakida N; Ko T; Shiraishi N; Adachi M; Tomita K; Kitamura K
J Hypertens; 2009 Jan; 27(1):181-9. PubMed ID: 19145783
[TBL] [Abstract][Full Text] [Related]
3. Hepatic and pancreatic metabolism and biliary excretion of the protease inhibitor camostat mesilate.
Beckh K; Weidenbach H; Weidenbach F; Müller R; Adler G
Int J Pancreatol; 1991; 10(3-4):197-205. PubMed ID: 1787334
[TBL] [Abstract][Full Text] [Related]
4. Increased 9,13-di-cis-retinoic acid in rat hepatic fibrosis: implication for a potential link between retinoid loss and TGF-beta mediated fibrogenesis in vivo.
Okuno M; Sato T; Kitamoto T; Imai S; Kawada N; Suzuki Y; Yoshimura H; Moriwaki H; Onuki K; Masushige S; Muto Y; Friedman SL; Kato S; Kojima S
J Hepatol; 1999 Jun; 30(6):1073-80. PubMed ID: 10406186
[TBL] [Abstract][Full Text] [Related]
5. The antifibrotic effect of a serine protease inhibitor in the kidney.
Morinaga J; Kakizoe Y; Miyoshi T; Onoue T; Ueda M; Mizumoto T; Yamazoe R; Uchimura K; Hayata M; Shiraishi N; Adachi M; Sakai Y; Tomita K; Kitamura K
Am J Physiol Renal Physiol; 2013 Jul; 305(2):F173-81. PubMed ID: 23698112
[TBL] [Abstract][Full Text] [Related]
6. Plasmin plays a key role in the regulation of profibrogenic molecules in hepatic stellate cells.
Martínez-Rizo A; Bueno-Topete M; González-Cuevas J; Armendáriz-Borunda J
Liver Int; 2010 Feb; 30(2):298-310. PubMed ID: 19889106
[TBL] [Abstract][Full Text] [Related]
7. Effect of proteinase inhibitor camostat mesilate on nephrotic syndrome with diabetic nephropathy.
Onbe T; Makino H; Kumagai I; Haramoto T; Murakami K; Ota Z
J Diabet Complications; 1991; 5(2-3):167-8. PubMed ID: 1770033
[TBL] [Abstract][Full Text] [Related]
8. The proteinase inhibitor camostat mesilate suppresses pancreatic pain in rodents.
Ishikura H; Nishimura S; Matsunami M; Tsujiuchi T; Ishiki T; Sekiguchi F; Naruse M; Nakatani T; Kamanaka Y; Kawabata A
Life Sci; 2007 May; 80(21):1999-2004. PubMed ID: 17433371
[TBL] [Abstract][Full Text] [Related]
9. Effect of camostat mesilate for the treatment of advanced diabetic nephropathy.
Matsubara M; Taguma Y; Kurosawa K; Hotta O; Suzuki K; Ishizaki M
J Lab Clin Med; 1990 Aug; 116(2):206-10. PubMed ID: 2394938
[TBL] [Abstract][Full Text] [Related]
10. Retinoids exacerbate rat liver fibrosis by inducing the activation of latent TGF-beta in liver stellate cells.
Okuno M; Moriwaki H; Imai S; Muto Y; Kawada N; Suzuki Y; Kojima S
Hepatology; 1997 Oct; 26(4):913-21. PubMed ID: 9328313
[TBL] [Abstract][Full Text] [Related]
11. [Effect of protease inhibitor on primary glomerulonephritis and the mechanism of the effect].
Onbe T; Makino H; Haramoto T; Wada J; Ogura T; Kumagai I; Murakami K; Fukushima M; Ota Z
Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):753-9. PubMed ID: 1770635
[TBL] [Abstract][Full Text] [Related]
12. Preventive and therapeutic effects of the protease inhibitor camostat on pancreatic fibrosis and atrophy in CCK-1 receptor-deficient rats.
Jia D; Taguchi M; Otsuki M
Pancreas; 2005 Jan; 30(1):54-61. PubMed ID: 15632700
[TBL] [Abstract][Full Text] [Related]
13. Camostat mesilate attenuates pancreatic fibrosis via inhibition of monocytes and pancreatic stellate cells activity.
Gibo J; Ito T; Kawabe K; Hisano T; Inoue M; Fujimori N; Oono T; Arita Y; Nawata H
Lab Invest; 2005 Jan; 85(1):75-89. PubMed ID: 15531908
[TBL] [Abstract][Full Text] [Related]
14. Treatment of ulcerative colitis with camostat mesilate, a serine protease inhibitor.
Senda S; Fujiyama Y; Bamba T; Hosoda S
Intern Med; 1993 Apr; 32(4):350-4. PubMed ID: 8358131
[TBL] [Abstract][Full Text] [Related]
15. Neovessel formation promotes liver fibrosis via providing latent transforming growth factor-β.
Sakata K; Eda S; Lee ES; Hara M; Imoto M; Kojima S
Biochem Biophys Res Commun; 2014 Jan; 443(3):950-6. PubMed ID: 24361885
[TBL] [Abstract][Full Text] [Related]
16. Gabexate mesilate, a synthetic protease inhibitor, reduces ischemia/reperfusion injury of rat liver by inhibiting leukocyte activation.
Harada N; Okajima K; Kushimoto S
Crit Care Med; 1999 Sep; 27(9):1958-64. PubMed ID: 10507625
[TBL] [Abstract][Full Text] [Related]
17. Suppressive effect of camostat mesilate (FOY 305) on acute experimental allergic encephalomyelitis (EAE).
Inuzuka T; Sato S; Baba H; Miyatake T
Neurochem Res; 1988 Mar; 13(3):225-8. PubMed ID: 2455235
[TBL] [Abstract][Full Text] [Related]
18. Effect of camostat mesilate on puromycin aminonucleoside nephrotic rats.
Suzuki J; Suzuki S; Nozawa R; Kumaki S; Kume K; Higuchi E; Kamiyama S; Ohara N; Yugeta E; Kato K
Fukushima J Med Sci; 1988 Jun; 34(1):21-5. PubMed ID: 3254858
[No Abstract] [Full Text] [Related]
19. Refractory chronic urticaria treated effectively with the protease inhibitors, nafamostat mesilate and camostat mesilate.
Takahagi S; Shindo H; Watanabe M; Kameyoshi Y; Hide M
Acta Derm Venereol; 2010 Jul; 90(4):425-6. PubMed ID: 20574618
[No Abstract] [Full Text] [Related]
20. Anti-TGF-beta strategies for the treatment of chronic liver disease.
Breitkopf K; Haas S; Wiercinska E; Singer MV; Dooley S
Alcohol Clin Exp Res; 2005 Nov; 29(11 Suppl):121S-131S. PubMed ID: 16344596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
